BMO Capital: 'Allstate (ALL) Biggest Beneficiary of Insurance Reforms'
July 10, 2026 9:30 AM
BMO Capital analyst Michael Zaremski reiterated an Outperform rating and $249.00 price target on Allstate (NYSE: ALL).The analyst commented: "Allstate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
